The total return over the past 12 months is -90.01% vs. +16.94% for the S&P 500. So far it's up -83.23% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (90.01%) | (20.15%) | (45.88%) | (25.43%) | (22.73%) | N/A |
| Total Return CAGR | (90.01%) | (20.14%) | (45.88%) | (25.43%) | (22.73%) | N/A |
| Revenue CAGR | (78.16%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
DataMEDS AI, Inc. (MEDS)
| Year | Start price | End price | MEDS Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $19.98 | $3.35 | (83.23%) | +14.51% | (97.74%) |
| 2025 | $7.59 | $19.98 | +163.24% | +17.72% | +145.52% |
| 2024 | $5.20 | $7.59 | +45.96% | +24.89% | +21.07% |
| 2023 | $6.04 | $5.20 | (13.91%) | +26.19% | (40.10%) |
| 2022 | $35.38 | $6.04 | (82.93%) | (18.17%) | (64.76%) |
| 2021 | $79.31 | $35.38 | (55.39%) | +28.74% | (84.13%) |
| 2020 | $98.95 | $79.31 | (19.85%) | +18.37% | (38.22%) |
| 2019 | $26.99 | $98.95 | +266.62% | +31.22% | +235.40% |
| 2018 | $40.48 | $26.99 | (33.33%) | (4.56%) | (28.77%) |
| 2017 | $41.38 | $40.48 | (2.17%) | +21.70% | (23.87%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
